Memantine and alanine aminotransferase increased Patient Reports February 12, 2012

Memantine Side Effects Report #6138439-9
Memantine side effect was reported by a Physician from UNITED STATES on Mar 27, 2009. Male patient, weighting 128.3 lb, was diagnosed with neoplasm and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, confusional state, dizziness , hyponatraemia. Memantine dosage: 90 MG. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6058165-4
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Jan 16, 2009. Female patient, 89 years of age, weighting 99.21 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct obstruction, gamma-glutamyltransferase increased. Memantine dosage: 20 MG (10 MG, 2 IN 1 D) ,ORAL. During the same period patient was treated with OMEPRAZOLE, DAFLON, IMOVANE. Patient recovered.

Memantine Side Effects Report #4848755-6
Memantine side effect was reported by a Health Professional from FRANCE on Nov 24, 2005. Male patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, infection , malaise, septic shock, transaminases increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with THIORIDAZINE, ASPIRIN, ENALAPRIL MALEATE, AMLODIPINE BESYLATE, NOOTROPYL. Patient recovered.

Memantine Side Effects Report #4922744-5
Memantine side effect was reported by a Health Professional from FRANCE on Feb 14, 2006. Male patient, 87 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased, infection , malaise, septic shock. Memantine dosage: 20 MG QD PO. During the same period patient was treated with THIORIDAZINE, ASPIRIN, ENALAPRIL MALEATE, AMLODIPINE BESYLATE, NOOTROPYL. Patient recovered.


Memantine Side Effects Report #5575721-8
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Dec 11, 2007. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, c-reactive protein increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5692109-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Mar 18, 2008. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood cholinesterase decreased, blood creatinine increased, blood glucose increased, blood urea increased, cholecystitis. Memantine dosage: 20 MG QD PO. During the same period patient was treated with DONEPEZIL, PROPIVERINE, ANTIBIOTIC, MAGNESIUM OXIDE, TRIMEBUTINE, GLYBURIDE. Patient was hospitalized. Patient died on 01/19/2008.

Memantine Side Effects Report #5201428-2
Memantine side effect was reported by a Health Professional from ITALY on Dec 28, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, computerised tomogram abnormal, diplopia, fibrosis, gamma-glutamyltransferase increased, ophthalmoplegia, strabismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIZEM, CENTRUM, B VITAMINE, EPHANYL, EPARGRISEOVIT. Patient recovered.

Memantine Side Effects Report #5142877-0
Memantine side effect was reported by a Health Professional from ITALY on Oct 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, ophthalmoplegia, strabismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Memantine Side Effects Report #5146293-7
Memantine side effect was reported by a Health Professional from ITALY on Oct 18, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, extraocular muscle paresis, fibrosis, gamma-glutamyltransferase increased, strabismus, ultrasound doppler abnormal. Memantine dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.


Memantine Side Effects Report #5173228-3
Memantine side effect was reported by a Health Professional from ITALY on Nov 10, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, diplopia, disorientation, gamma-glutamyltransferase increased, mydriasis, ophthalmoplegia, strabismus. Memantine dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Memantine Side Effects Report #5179948-9
Memantine side effect was reported by a Health Professional from ITALY on Nov 24, 2006. Female patient, 83 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, cerebral ventricle dilatation, computerised tomogram abnormal, dementia alzheimer's type, diplopia, disease progression, disorientation, eye movement disorder. Memantine dosage: 10 MG BID PO. During the same period patient was treated with VERAPAMIL, CARDIRENE, CENTRUM, B VITAMINE, EPHYNAL, EPARGRISEOVIT. Patient recovered.

Memantine Side Effects Report #5310147-3
Memantine side effect was reported by a Health Professional from JAPAN on Apr 12, 2007. Male patient, 80 years of age, weighting 87.96 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood lactate dehydrogenase increased, blood pressure decreased, blood pressure systolic decreased, decubitus ulcer, depressed level of consciousness, productive cough. Memantine dosage: unknown. During the same period patient was treated with CERNITIN POLLEN, TAMSULOSIN, MAGNESIUM OXIDE, EPINASTINE HYDROCHLORIDE, CROTAMITON. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4767726-1
Memantine side effect was reported by a Health Professional from GERMANY on Aug 29, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood fibrinogen increased, blood lactate dehydrogenase increased, blood potassium decreased, blood pressure increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTOZOLAM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4963734-6
Memantine side effect was reported by a Health Professional from JAPAN on Oct 03, 2005. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ammonia increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4984588-8
Memantine side effect was reported by a Health Professional from JAPAN on Apr 12, 2006. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, ammonia increased, ascites, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5036482-4
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on June 12, 2006. Male patient, 74 years of age, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, bile duct stone, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatine phosphokinase increased, blood creatinine increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SULPIRIDE, TOCOPHEROL NICOTINATE, BROTIZOLAM, DONEPEZIL HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6081483-0
Memantine side effect was reported by a Health Professional from GERMANY on Feb 10, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood glucose increased, blood uric acid increased, deep vein thrombosis , fibrin degradation products increased, gamma-glutamyltransferase increased, haemorrhage, platelet count decreased. Memantine dosage: 20 MG (20 MG, 1 IN 1 D), ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6122223-6
Memantine side effect was reported by a Health Professional from GERMANY on Mar 04, 2009. Male patient, 72 years of age, weighting 132.3 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood albumin decreased, blood creatine increased, blood glucose increased, blood uric acid increased, deep vein thrombosis , epilepsy , gamma-glutamyltransferase increased, international normalised ratio decreased. Memantine dosage: 20 MG (20 MG,1 IN 1 D),ORAL. During the same period patient was treated with DIMETHICONE, MOMETASONE FUROATE, DEPRODONE PROPIONATE, DEXAMETHASONE DRY DISTILLATION TAR OF DEFATTING SOYBEAN, INDOMETHACIN, SENNOSIDE, BIFIDOBACTERIUM. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5067213-X
Memantine side effect was reported by a Health Professional from JAPAN on July 20, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, albumin globulin ratio abnormal, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.


Memantine Side Effects Report #5110836-X
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Sept 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood chloride decreased, blood cholinesterase decreased, blood creatine phosphokinase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #5748899-0
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2008. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, abdominal pain , alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased. Memantine dosage: 20 MG QD;PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #4913543-9
Memantine side effect was reported by a Health Professional from JAPAN on Jan 31, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aspartate aminotransferase increased, band neutrophil percentage increased, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE, HYDROXYZINE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4922747-0
Memantine side effect was reported by a Health Professional from JAPAN on Feb 10, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4937122-2
Memantine side effect was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: abasia, alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, blood calcium decreased, blood cholinesterase decreased, blood glucose increased, blood lactate dehydrogenase decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #4988330-6
Memantine side effect was reported by a Health Professional from JAPAN on Apr 11, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, anorexia, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #4990003-0
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Apr 25, 2006. Male patient, 68 years of age, weighting 110.2 lb, was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, albumin globulin ratio decreased, aspartate aminotransferase increased, b-cell lymphoma stage iv, blood calcium decreased, blood chloride decreased, blood glucose increased, blood lactate dehydrogenase increased, blood potassium decreased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with HYDROXYZINE, ZOLPIDEM TARTRATE, METOPROLOL TARTRATE, TRAZODONE. Patient was hospitalized. Patient died on 03/29/2006.

Memantine Side Effects Report #6010146-2
Memantine side effect was reported by a Pharmacist from GERMANY on Dec 02, 2008. Female patient was diagnosed with dementia alzheimer's type and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anxiety , blood bilirubin increased, blood glucose fluctuation, faeces pale, fall , gamma-glutamyltransferase increased, jaundice , liver disorder. Memantine dosage: 20 MG (20 MG,1 IN 1 D), ORAL. During the same period patient was treated with METFORMIN, GLIBENKLAMID, ASPIRIN, ALVEDON, ATARAX, ZOPIKLON, HERACELLIN. Patient recovered.

Memantine Side Effects Report #4970340-6
Memantine side effect was reported by a Health Professional from FRANCE on Mar 22, 2006. Female patient, 92 years of age, weighting 121.3 lb, was diagnosed with dementia , insomnia, agitation and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anti-hbs antibody positive, aspartate aminotransferase increased, biliary dilatation, blood alkaline phosphatase increased, c-reactive protein increased, cholelithiasis, gallbladder disorder, gamma-glutamyltransferase increased. Memantine dosage: 10 MG BID PO. During the same period patient was treated with STILNOX, ALDALIX, CORVASAL, TIAPRIDAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5941092-8
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Oct 17, 2008. Female patient, 83 years of age, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial fibrillation , cor pulmonale acute, international normalised ratio increased, pulmonary embolism . Memantine dosage: 10 MG (10 MG, 1 IN 1 D), ORAL. During the same period patient was treated with XALATAN, COSOPT, NYCOPLUS VITAMIN D. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5974219-2
Memantine side effect was reported by a Pharmacist from GERMANY on Nov 14, 2008. Male patient, 76 years of age, weighting 149.9 lb, was diagnosed with dementia  and was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary colic, bilirubin conjugated increased, blood bilirubin increased, vomiting. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with VERAPAMIL, CENTRUM SELECT. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5380529-2
Memantine side effect was reported by a Consumer or non-health professional from GREECE on June 18, 2007. Female patient, 94 years of age, weighting 110.2 lb, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, gamma-glutamyltransferase increased. Memantine dosage: 20 MG QD PO. During the same period patient was treated with SEROQUEL, SALOSPIR, THYROHORMONE. Patient recovered.

Memantine Side Effects Report #4766366-8
Memantine side effect was reported by a Pharmacist from FRANCE on Aug 26, 2005. Male patient, 71 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, c-reactive protein increased, convulsion, creatine phosphokinase decreased, creatinine renal clearance decreased, erysipelas. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, PREVISCAN, LOVENOX, PENICILLIN G. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #4785156-3
Memantine side effect was reported by a Health Professional from FRANCE on Sept 16, 2005. Male patient, 71 years of age, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase decreased, c-reactive protein increased, convulsion, creatine phosphokinase decreased, creatinine renal clearance decreased, erysipelas. Memantine dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, PREVISCAN, LOVENOX, PENICILLIN G. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #5878506-8
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Male patient was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, vomiting. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.


Memantine Side Effects Report #5878510-X
Memantine side effect was reported by a Consumer or non-health professional from GERMANY on Aug 26, 2008. Male patient was treated with Memantine. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, vomiting. Memantine dosage: 5 MG (5 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Memantine Side Effects Report #6138423-5
Memantine side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 27, 2009. Male patient, weighting 128.3 lb, was treated with Memantine. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, confusional state, dizziness , hyponatraemia. Memantine dosage: 90 MG. Patient was hospitalized. Patient recovered.